These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 916095)

  • 1. Complications of partial cystectomy in patients with high grade bladder carcinoma.
    Peress JA; Waterhouse K; Cole AT
    J Urol; 1977 Nov; 118(5):761. PubMed ID: 916095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indication of radical cystectomy in patients with carcinoma of the bladder.
    de Riese W; Esk P; Schindler E
    Int Urol Nephrol; 1987; 19(4):393-8. PubMed ID: 3429166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.
    Frazier HA; Robertson JE; Dodge RK; Paulson DF
    Cancer; 1993 Jun; 71(12):3993-4001. PubMed ID: 8508365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of 34 cases of infiltrating carcinoma of the bladder treated exclusively with partial cystectomy (part 1)].
    Escudero Barrilero A; Fernández Fernández E; Jiménez Cidre M; Maganto Pavón E; Mayayo Dehesa T; Rodríguez Rodríguez R; Galvis San Juan F; Burgos Revilla FJ
    Arch Esp Urol; 1996 May; 49(4):349-64. PubMed ID: 8754191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A stage specific approach to tumor surveillance after radical cystectomy for transitional cell carcinoma of the bladder.
    Slaton JW; Swanson DA; Grossman HB; Dinney CP
    J Urol; 1999 Sep; 162(3 Pt 1):710-4. PubMed ID: 10458349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of high-risk non-muscle invasive bladder cancer.
    Brausi M; Olaru V
    Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder.
    Amling CL; Thrasher JB; Frazier HA; Dodge RK; Robertson JE; Paulson DF
    J Urol; 1994 Jan; 151(1):31-5; discussion 35-6. PubMed ID: 8254828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
    Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
    J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EFFICACY OF DIFFERENT RESECTIONS ON NON-MUSCLE-INVASIVE BLADDER CANCER AND ANALYSIS OF THE OPTIMAL SURGICAL METHOD.
    Chen GF; Shi TP; Wang BJ; Wang XY; Zang Q
    J Biol Regul Homeost Agents; 2015; 29(2):465-70. PubMed ID: 26122238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of partial cystectomy for carcinoma of bladder.
    Faysal MH; Freiha FS
    Urology; 1979 Oct; 14(4):352-6. PubMed ID: 494462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of panurothelial disease in superficial bladder cancer.
    Srougi M; Antunes AA; Dall'Oglio MF; Cury J
    Nat Clin Pract Urol; 2006 May; 3(5):284-8. PubMed ID: 16691242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of repeat transurethral resection in the management of high-risk superficial transitional cell bladder cancer.
    Sivalingam S; Probert JL; Schwaibold H
    BJU Int; 2005 Oct; 96(6):759-62. PubMed ID: 16153194
    [No Abstract]   [Full Text] [Related]  

  • 14. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
    Kassouf W; Swanson D; Kamat AM; Leibovici D; Siefker-Radtke A; Munsell MF; Grossman HB; Dinney CP
    J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: patterns of initial transitional cell recurrence in patients after cystectomy.
    Zaghloul MS
    J Urol; 2007 Aug; 178(2):730; author reply 730. PubMed ID: 17574607
    [No Abstract]   [Full Text] [Related]  

  • 16. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological features of recurrence after radical cystectomy for patients with transitional cell carcinoma of the bladder.
    Harada K; Sakai I; Kurahashi T; Muramaki M; Yamanaka K; Hara I; Eto H; Miyake H
    Int Urol Nephrol; 2006; 38(1):49-55. PubMed ID: 16502052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bladder cancer--resection/ablation.
    Corica FA; Keane TE
    Surg Oncol Clin N Am; 2005 Apr; 14(2):321-52. PubMed ID: 15817242
    [No Abstract]   [Full Text] [Related]  

  • 19. [Partial cystectomy versus TUR in T1G3 tumors].
    Manca GP; Martina G; Piras P; D'Alpaos M; Scuzarella S; Andreassi F
    Arch Ital Urol Androl; 1996 Feb; 68(1):33-4. PubMed ID: 8664918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of CA 125 in transitional cell carcinoma of the bladder.
    Manvar AM; Wallen EM; Pruthi RS; Nielsen ME
    Expert Rev Anticancer Ther; 2010 Dec; 10(12):1877-81. PubMed ID: 21110754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.